Skip to main content
Incretin/triple-agonist and metabolic peptides studied for weight management and metabolic regulation.

A claim about your health looks wrong

How can you flag a study result that seems wrong?

A promise about strength can go beyond the test. You can report a wrong finding, a missed study, or changed drug approval.

What can you send when a finding looks wrong?

Quote the finding you question and name its page. We read concerns about wrongly reported findings and changed drug approval. We also read notes about published MOTS-c or tesamorelin papers we've missed. You can find the studies used in the paper list.

Your plain account of the problem is enough.

If you have a supporting paper, send the link or give the title and an author's name. That helps us find and check the result. You don't need a special paper number or a rewritten page. We read correction notes closely, but we can't promise a reply.

Email the concern you found: editors@tsmmapeptides.com

Where can your own care questions be answered?

A doctor who can examine you can discuss your treatment. We read studies and correction notes here. We don't run a clinic or sales service. Your care can't be decided through this mailbox.

This address handles research errors, not personal treatment.

  • We can't advise on using MOTS-c or tesamorelin in people.
  • We can't tell you how much to take or how to take a peptide.
  • We can't diagnose illness or predict your response.
  • We can't help locate or obtain either substance from a seller.
  • We can't advise athletes on use under sport rules. Both substances are banned in sport.

A doctor licensed where you live can address medical questions. Correction mail is checked from time to time. You may have to wait, and we can't promise a reply. You can send a concern about a published finding here. If you want to know whether your health could improve with treatment, you'll need someone who can assess you, because a mailbox for research errors can't provide the care behind that decision.